Dr. Peter A. Najjar discusses the impact of artificial intelligence on healthcare, specifically cancer detection.
Dr. Peter A. Najjar, Vice President of Clinical Innovation at Johns Hopkins Health System, explains how AI is rapidly transforming healthcare, particularly in cancer research and patient treatment. He highlights AI’s role in accelerating drug discovery and detecting diseases like pancreatic cancer earlier than human readers. The discussion also covers the impact of AI scribes on improving physician-patient interactions, enhancing efficiency, and focusing on patient care.
Read the full article here
